Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peptidase domain containing associated with muscle regeneration 1 (PAMR1) is a secreted protein that contains an inactive serine protease domain, CUB, EGF, and Sushi domains. It is thought to play a role in the regeneration of skeletal muscle, being induced upon muscle injury and downregulated in Duchenne muscular dystrophy. PAMR1 acts as a putative tumor suppressor; its expression is frequently suppressed in cancers, especially breast cancer, due to promoter hypermethylation. Restoration of PAMR1 expression suppresses tumor cell growth, and its methylation status is being investigated as a biomarker for cancer diagnosis and prognosis. Although it is structurally related to serine proteases, PAMR1 is predicted to lack enzymatic activity but may function in protein-protein interactions and modulation of growth factor signaling. No direct drugs are currently known to interact with PAMR1, but epigenetic drugs may indirectly affect its activity via demethylation
Demethylating agents: Reactivate silenced PAMR1 via promoter hypomethylation, potentially restoring tumor suppressor function. No known direct inhibitors or molecular-targeted drugs for PAMR1
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peptidase domain containing associated with muscle regeneration 1 (PAMR1).